Abstract
Background
Therapeutic outcomes for most patients with early gastric cancer are favorable. However, mortality among these patients remains a concern. Improvements in therapeutic outcomes are being sought by studying the timing and causes of death. Here, the results of surgery were evaluated to assess the appropriate treatment and follow-up schedule for early gastric cancer.
Methods
A total of 1169 patients with early gastric cancer underwent curative gastrectomy between 1992 and 1999. Survival time, prognostic factors, cause of death, and time of death were evaluated retrospectively.
Results
Multivariate analysis of disease-specific survival identified lymph node metastasis as an independent prognostic factor. The anatomical extent of lymph node metastasis and the number of metastatic lymph nodes influenced the rate of recurrence. Multivariate analysis of overall survival identified age as a prognostic factor. A total of 91 patients (7.8%) from the study group died: 56 from comorbid diseases, 21 from gastric cancer, and 14 from other second primary cancers. Death from gastric cancer was frequently observed within 5 years of surgical resection, whereas death from other diseases usually occurred after 5 years. Patients who died as a result of diseases other than gastric cancer tended to be older.
Conclusions
Appropriate lymph node dissection is necessary for patients with early gastric cancer, particularly those with risk factors associated with lymph node metastasis. Meticulous follow-up protocols that can detect second primary cancers, together with the development of treatments for comorbid diseases, are required to improve survival.
Similar content being viewed by others
References
Tominaga S, Aoki K, Fujimoto I, et al. Cancer mortality and morbidity statistics. Japan and the world—1994. Gann Monogr Cancer Res 1994; 41:175–7
Murakami T. Pathomorphological diagnosis: definition and gross classification of early gastric cancer. Gann Monogr Cancer Res 1971; 11:53–5
Fukao A, Tsubono Y, Tsuji I, et al. The evaluation of screening for gastric cancer in Miyagi prefecture, Japan. A population-based case-control study. Int J Cancer 1995; 60:45–8
Mori Y, Arita T, Shimoda K, et al. Effect of periodic endoscopy for gastric cancer on early detection and improvement of survival. Gastric Cancer 2001; 4:132–6
Fujii M, Sasaki J, Nakajima T. State of the art in the treatment of gastric cancer: from the 71st Japanese Gastric Cancer Congress. Gastric Cancer 1999; 2:151–7
Arai J, Yamada H, Maruyama M. Initial radiographic findings of early gastric cancer detected in health check programs and human “dry dock” (multiphasic screening) collective health checks and treated by endoscopic mucosal resection. Gastric Cancer 2002; 5:35–42
Kitano S, Shiraishi N, Kakisako K, et al. Laparoscopy-assisted Billroth-I gastrectomy (LADG) for cancer: our 10 years’ experience. Surg Laparosc Endosc Percutan Tech 2002; 12:204–7
Kitano S, Shiraishi N. Current status of laparoscopic gastrectomy for cancer in Japan. Surg Endosc 2004; 18:182–5
Nakajima T. Gastric cancer treatment guidelines in Japan. Gastric Cancer 2002; 5:1–5
Kunisaki C, Shimada H, Nomura M, et al. Appropriate lymph node dissection for early gastric cancer based on lymph node metastases. Surgery 2001; 129:153–7
Kunisaki C, Shimada H, Takahashi M, et al. Prognostic factors in early gastric cancer. Hepatogastroenterology 2001; 48:294–8
Ikeda Y, Saku M, Kawanaka H, et al. Features of second primary cancer in patients with gastric cancer. Oncology 2003; 65:113–7
Ikeda Y, Saku M, Kishihara F, et al. Effective follow-up for recurrence or a second primary cancer in patients with early gastric cancer. Br J Surg 2004; 92:235–9
Japanese Gastric Cancer Association. Japanese classification of gastric cancer: 2nd English edition. Gastric Cancer 1998; 1:8–24
Hosokawa O, Watanabe K, Hatorri M, et al. Detection of gastric cancer by repeat endoscopy within a short time after negative examination. Endoscopy 2001; 33:301–5
Abe S, Izuishi K, Tajiri H, et al. Correlation of in vitro autofluorescence endoscopy images with histopathologic findings in stomach cancer. Endoscopy 2000; 32:281–6
Borie F, Plaisant N, Millat B, et al. French Associations for Surgical Research. Appropriate gastric resection with lymph node dissection for early gastric cancer. Ann Surg Oncol 2004; 11:512–7
Kim JP, Hur YS, Yang HK. Lymph node metastasis as a significant prognostic factor in early gastric cancer: analysis of 1,136 early gastric cancers. Ann Surg Oncol 1995; 2:308–13
Popiela T, Kulig J, Kolodziejczyk P, et al. Polish Gastric Cancer Study Group. Long-term results of surgery for early gastric cancer. Br J Surg 2002; 89:1035–42
Otsuji E, Kuriu Y, Ichikawa D, et al. Tumor recurrence and its timing following curative resection of early gastric carcinoma. Anticancer Res 2003; 23:3499–503
Bando E, Kojima N, Kawamura T, et al. Prognostic value of age and sex in early gastric cancer. Br J Surg 2004; 91:1197–201
Kodera Y, Ito S, Yamamura Y, et al. A follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol 2003; 10:898–902
Arai W, Hosoya Y, Hyodo M, et al. Alternate-day oral therapy with TS-1 for advanced gastric cancer. Int J Clin Oncol 2004; 9:143–8
Park SH, Kang WK, Lee HR, et al. Docetaxel plus cisplatin as second-line therapy in metastatic or recurrent advanced gastric cancer progressing on 5-fluorouracil-based regimen. Am J Clin Oncol 2004; 27:477–80
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kunisaki, C., Akiyama, H., Nomura, M. et al. Significance of Long-Term Follow-Up of Early Gastric Cancer. Ann Surg Oncol 13, 363–369 (2006). https://doi.org/10.1245/ASO.2006.03.061
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/ASO.2006.03.061